| |
|
|
|
xtalks.com, webinar
Friday, February 04, 2022 | 4pm EST
Who Should Attend?This webinar will appeal to: - Founder/CEO/CSO
- Chief Medical Officer
- R&D Manager, Director
- QC & Process Development Manager
- Principal Scientist
- Clinical Scientists
- Research Scientist/Associate
What You Will LearnJoin this webinar to learn about: - Extensive end-to-end analysis features and unmatched performance of the cloud-based cytometry analysis software
- Rigorous validation and comprehensive 21 CFR part 11-compliance features which are an excellent fit for regulated environments
- Analyzing longitudinal clinical studies with metadata-driven visualizations
- The ease of reproducibly analyzing datasets containing thousands of samples with speed and rich API
|
|
|
|
|
|
|
|
Organized by:
|
|
xtalks.com |
|
|
Invited Speakers:
|
|
SpeakersZachary Bjornson-Hooper, PhD, Sr. Director, Informatics, CellCartaDr. Bjornson-Hooper completed his undergraduate studies in biology at the Massachusetts Institute of Technology and earned his PhD in microbiology and immunology at Stanford University. He has extensive wet lab experience in comparative immunology, flow and mass cytometry and viral genomics, including leading the development of an atlas of immune signaling responses in various animal models relevant to infectious disease research. Additionally, he has 15 years of experience in bioinformatic analysis of CyTOF, flow cytometry and viral metagenomic data. At CellCarta, he oversees the development of the CellEngine single-cell analysis platform. Message PresenterDave McIlwain, PhD, Senior Research Scientist, Stanford University School of Medicine, Nolan LabDr. McIlwain studies host response to infections using high-dimensional single-cell and spatial proteomics tools. He trained for his PhD at the University of Toronto, yielding insights into alternative mRNA splicing and iRhom2 as a new factor controlling the production of inflammatory mediator TNF. As a post-doctoral fellow, Dr. McIlwain investigated host response to viral infection in animal models at the University of Dusseldorf in Germany before moving to Stanford University where, along with Dr. Garry Nolan, he leads a team executing research contracted by the FDA’s Medical Countermeasures Initiative to study emerging pathogens. This work includes mass cytometry (CyTOF) and spatial proteomic (CODEX) single-cell analysis of human and animal model influenza, Ebola, zika and SARS-CoVs infections. Message PresenterPier Federico Gherardini, PhD, Computational Biology Consultant, Pragmatica.BioDr. Gherardini has 14 years of experience in computational biology and bioinformatics. Dr. Gherardini obtained his PhD from the University of Rome Tor Vergata, and subsequently moved to Stanford for postdoctoral training. Dr. Gherardini has developed computational tools for the analysis of cytometry data and a technology to measure gene expression in single cells using mass cytometry. Most recently, Dr. Gherardini was Director of Informatics at the Parker Institute for Cancer Immunotherapy. While at the Parker Institute, Dr. Gherardini designed the CANDEL platform for the integration of clinical and molecular data from patient samples and led a team of scientists to analyze deep immune profiling data from clinical trials in immuno-oncology. |
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
na
|
|
|
|
|
|
|
|
Registration:
|
|
https://xtalks.com/webinars/https-xtalks-com-webinars-fast-metadata-driven-analysis-and-visualization-flow-and-mass-cytometry-data-cellengine/
|
|
|
E-mail:
|
|
shunte@xtalks.com
|
|
|
|
|
|
|
|
|
